Literature DB >> 21444879

Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: the Atherosclerosis Risk in Communities (ARIC) study.

Rachel R Huxley1, Faye L Lopez, Aaron R Folsom, Sunil K Agarwal, Laura R Loehr, Elsayed Z Soliman, Rich Maclehose, Suma Konety, Alvaro Alonso.   

Abstract

BACKGROUND: Atrial fibrillation (AF) is an important risk factor for stroke and overall mortality, but information about the preventable burden of AF is lacking. The aim of this study was to determine what proportion of the burden of AF in blacks and whites could theoretically be avoided by the maintenance of an optimal risk profile. METHODS AND
RESULTS: This study included 14 598 middle-aged Atherosclerosis Risk in Communities (ARIC) Study cohort members. Previously established AF risk factors, namely high blood pressure, elevated body mass index, diabetes mellitus, cigarette smoking, and prior cardiac disease, were categorized into optimal, borderline, and elevated levels. On the basis of their risk factor levels, individuals were classified into 1 of these 3 groups. The population-attributable fraction of AF resulting from having a nonoptimal risk profile was estimated separately for black and white men and women. During a mean follow-up of 17.1 years, 1520 cases of incident AF were identified. The age-adjusted incidence rates were highest in white men and lowest in black women (7.45 and 3.67 per 1000 person-years, respectively). The overall prevalence of an optimal risk profile was 5.4% but varied according to race and gender: 10% in white women versus 1.6% in black men. Overall, 56.5% of AF cases could be explained by having ≥ 1 borderline or elevated risk factors, of which elevated blood pressure was the most important contributor.
CONCLUSION: As with other forms of cardiovascular disease, more than half of the AF burden is potentially avoidable through the optimization of cardiovascular risk factors levels.

Entities:  

Mesh:

Year:  2011        PMID: 21444879      PMCID: PMC3181498          DOI: 10.1161/CIRCULATIONAHA.110.009035

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  24 in total

1.  Absolute and attributable risks of cardiovascular disease incidence in relation to optimal and borderline risk factors: comparison of African American with white subjects--Atherosclerosis Risk in Communities Study.

Authors:  Atsushi Hozawa; Aaron R Folsom; A Richey Sharrett; Lloyd E Chambless
Journal:  Arch Intern Med       Date:  2007-03-26

2.  A SAS macro for estimation of direct adjusted survival curves based on a stratified Cox regression model.

Authors:  Xu Zhang; Fausto R Loberiza; John P Klein; Mei-Jie Zhang
Journal:  Comput Methods Programs Biomed       Date:  2007-09-11       Impact factor: 5.428

3.  Distinct heritable patterns of angiographic coronary artery disease in families with myocardial infarction.

Authors:  Marcus Fischer; Ulrich Broeckel; Stephan Holmer; Andrea Baessler; Christian Hengstenberg; Bjoern Mayer; Jeanette Erdmann; Gernot Klein; Guenter Riegger; Howard J Jacob; Heribert Schunkert
Journal:  Circulation       Date:  2005-02-14       Impact factor: 29.690

Review 4.  Global burden of blood-pressure-related disease, 2001.

Authors:  Carlene M M Lawes; Stephen Vander Hoorn; Anthony Rodgers
Journal:  Lancet       Date:  2008-05-03       Impact factor: 79.321

5.  Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence.

Authors:  Yoko Miyasaka; Marion E Barnes; Bernard J Gersh; Stephen S Cha; Kent R Bailey; Walter P Abhayaratna; James B Seward; Teresa S M Tsang
Journal:  Circulation       Date:  2006-07-03       Impact factor: 29.690

6.  Prevention of atrial fibrillation: report from a national heart, lung, and blood institute workshop.

Authors:  Emelia J Benjamin; Peng-Sheng Chen; Diane E Bild; Alice M Mascette; Christine M Albert; Alvaro Alonso; Hugh Calkins; Stuart J Connolly; Anne B Curtis; Dawood Darbar; Patrick T Ellinor; Alan S Go; Nora F Goldschlager; Susan R Heckbert; José Jalife; Charles R Kerr; Daniel Levy; Donald M Lloyd-Jones; Barry M Massie; Stanley Nattel; Jeffrey E Olgin; Douglas L Packer; Sunny S Po; Teresa S M Tsang; David R Van Wagoner; Albert L Waldo; D George Wyse
Journal:  Circulation       Date:  2009-02-03       Impact factor: 29.690

7.  Heart failure incidence and survival (from the Atherosclerosis Risk in Communities study).

Authors:  Laura R Loehr; Wayne D Rosamond; Patricia P Chang; Aaron R Folsom; Lloyd E Chambless
Journal:  Am J Cardiol       Date:  2008-02-14       Impact factor: 2.778

8.  Cigarette smoking and risk of atrial fibrillation: the Rotterdam Study.

Authors:  Jan Heeringa; Jan A Kors; Albert Hofman; Frank J A van Rooij; Jacqueline C M Witteman
Journal:  Am Heart J       Date:  2008-10-14       Impact factor: 4.749

9.  Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Alvaro Alonso; Sunil K Agarwal; Elsayed Z Soliman; Marietta Ambrose; Alanna M Chamberlain; Ronald J Prineas; Aaron R Folsom
Journal:  Am Heart J       Date:  2009-07       Impact factor: 4.749

10.  Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

Authors:  Wayne Rosamond; Katherine Flegal; Karen Furie; Alan Go; Kurt Greenlund; Nancy Haase; Susan M Hailpern; Michael Ho; Virginia Howard; Brett Kissela; Bret Kissela; Steven Kittner; Donald Lloyd-Jones; Mary McDermott; James Meigs; Claudia Moy; Graham Nichol; Christopher O'Donnell; Veronique Roger; Paul Sorlie; Julia Steinberger; Thomas Thom; Matt Wilson; Yuling Hong
Journal:  Circulation       Date:  2007-12-17       Impact factor: 29.690

View more
  173 in total

1.  Heart disease and stroke statistics--2012 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Elsayed Z Soliman; Paul D Sorlie; Nona Sotoodehnia; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2011-12-15       Impact factor: 29.690

2.  Risk of Malignant Cancer Among Women With New-Onset Atrial Fibrillation.

Authors:  David Conen; Jorge A Wong; Roopinder K Sandhu; Nancy R Cook; I-Min Lee; Julie E Buring; Christine M Albert
Journal:  JAMA Cardiol       Date:  2016-07-01       Impact factor: 14.676

Review 3.  Renal denervation: effects on atrial electrophysiology and arrhythmias.

Authors:  Dominik Linz; Arne van Hunnik; Christian Ukena; Sebastian Ewen; Felix Mahfoud; Stephan H Schirmer; Matthias Lenski; Hans-Ruprecht Neuberger; Ulrich Schotten; Michael Böhm
Journal:  Clin Res Cardiol       Date:  2014-03-29       Impact factor: 5.460

Review 4.  Genetics of Atrial Fibrillation in 2020: GWAS, Genome Sequencing, Polygenic Risk, and Beyond.

Authors:  Carolina Roselli; Michiel Rienstra; Patrick T Ellinor
Journal:  Circ Res       Date:  2020-06-18       Impact factor: 17.367

Review 5.  Epidemiology of Atrial Fibrillation in the 21st Century: Novel Methods and New Insights.

Authors:  Jelena Kornej; Christin S Börschel; Emelia J Benjamin; Renate B Schnabel
Journal:  Circ Res       Date:  2020-06-18       Impact factor: 17.367

6.  Heart disease and stroke statistics--2014 update: a report from the American Heart Association.

Authors:  Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; Michael J Blaha; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Suzanne E Judd; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Rachel H Mackey; David J Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Robert W Neumar; Graham Nichol; Dilip K Pandey; Nina P Paynter; Matthew J Reeves; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2013-12-18       Impact factor: 29.690

7.  Etiology, Pathology, and Classification of Atrial Fibrillation.

Authors:  Srishti Nayak; Balaji Natarajan; Ramdas G Pai
Journal:  Int J Angiol       Date:  2020-03-29

Review 8.  The why, when and how to test for obstructive sleep apnea in patients with atrial fibrillation.

Authors:  Lien Desteghe; Jeroen M L Hendriks; R Doug McEvoy; Ching Li Chai-Coetzer; Paul Dendale; Prashanthan Sanders; Hein Heidbuchel; Dominik Linz
Journal:  Clin Res Cardiol       Date:  2018-04-12       Impact factor: 5.460

9.  Effect of an intensive lifestyle intervention on atrial fibrillation risk in individuals with type 2 diabetes: the Look AHEAD randomized trial.

Authors:  Alvaro Alonso; Judy L Bahnson; Sarah A Gaussoin; Alain G Bertoni; Karen C Johnson; Cora E Lewis; Marion Vetter; Christos S Mantzoros; Robert W Jeffery; Elsayed Z Soliman
Journal:  Am Heart J       Date:  2015-07-26       Impact factor: 4.749

10.  Predictors of non-pulmonary vein foci in paroxysmal atrial fibrillation.

Authors:  Keita Watanabe; Junichi Nitta; Osamu Inaba; Akira Sato; Yukihiro Inamura; Nobutaka Kato; Masahito Suzuki; Masahiko Goya; Kenzo Hirao; Tetsuo Sasano
Journal:  J Interv Card Electrophysiol       Date:  2020-05-28       Impact factor: 1.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.